ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $22.28 | N/A |
Market Cap | $1.07B | N/A |
Shares Outstanding | 47.89M | N/A |
Employees | 0 | N/A |